Screening Hepatitis Positive Women for Congenital Anomalies

Completed

• Conditions: Hepatitis C

• Registration Number: NCT03980301
• Lead Sponsor: Aljazeera Hospital

Brief Summary

Hepatitis C virus is one of the virulent viruses

Detailed Description

Hepatitius positive women should be screened for congenital anomalies

Study Timeline

• Study Start: 2018-10-11
• Study First Submitted: 2019-06-06
• Study First Submitted QC: 2019-06-06
• Study First Posted: 2019-06-10
• Primary Completion: 2020-06-15
• Status Verified: 2020-10
• Study Completion: 2020-10-20
• Last Update Submitted: 2020-10-31
• Last Update Posted: 2020-11-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• Pregnant women with hepatitis C virus received treatment during first trimester

Exclusion Criteria

• pregnant women with hepatitis C virus who didnot receive treatment during first trimester

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies	within 6 months	the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies by us

Trial Locations

Locations (1)

Algazeerah; 🇪🇬 Giza, Egypt